Literature DB >> 16835319

Cell cycle regulators p105, p107, Rb2/p130, E2F4, p21CIP1/WAF1, cyclin A in predicting cervical intraepithelial neoplasia, high-risk human papillomavirus infections and their outcome in women screened in three new independent states of the former Soviet Union.

Rosa Santopietro1, Irena Shabalova, Nicolay Petrovichev, Vladimir Kozachenko, Tatjana Zakharova, Julia Pajanidi, Jurij Podistov, Galina Chemeris, Larisa Sozaeva, Elena Lipova, Irena Tsidaeva, Olga Ivanchenko, Alla Pshepurko, Sergej Zakharenko, Raisa Nerovjna, Ludmila Kljukina, Oksana Erokhina, Marina Branovskaja, Maritta Nikitina, Valerija Grunberga, Alexandr Grunberg, Anna Juschenko, Marcella Cintorino, Piero Tosi, Kari Syrjänen, Stina Syrjänen.   

Abstract

BACKGROUND: The growth-controlling functions of the high-risk human papillomaviruses (HPV) depend on their ability to interact with several cellular proteins, including the key regulatory proteins of the cell cycle. We have examined the value of cell cycle regulatory proteins as predictors of the intermediate end point markers in cervical carcinogenesis: (a) grade of cervical intraepithelial neoplasia (CIN), (b) high-risk HPV type, (c) clearance/persistence of high-risk HPV, and (d) disease outcome in women participating in a multicenter follow-up study in three New Independent States countries.
METHODS: Totally, 232 biopsy samples tested high-risk HPV-positive and/or Papanicolaou smear-positive women were immunohistochemically stained for the following cell cycle markers: p105, p107, p130, E2F4, p21(CIP1/WAF1/SDI1), cyclin A, and Ki-67. In addition, apoptotic index (AI) and mitotic index (MI) were determined in H&E-stained sections. Prospective follow-up data were available to disclose the clinical and virological outcome of the lesions.
RESULTS: The expression of Ki-67, p21(CIP1/WAF1/SDI1), and cyclin A and AI and MI values were markedly increased in high-grade lesions, but only MI was an independent predictor of CIN3 in multivariate analysis. Cyclin A was the only independent predictor of high-risk HPV (odds ratio, 1.09; 95% confidence interval, 1.01-1.18; P = 0.021), exceeding the predictive power of CIN grade and high-grade squamous intraepithelial lesion Papanicolaou smears. None of these markers provided any useful predictive information as to the clinical and virological outcomes during the follow-up. Highly significant correlations (P = 0.0001) were found between AI and MI as well as between MI and cyclin A, Ki-67 and p21(CIP1/WAF1/SDI1), Ki-67 and cyclin A, and p21(CIP1/WAF1/SDI1) and cyclin A followed by that between p105 and cyclin A (P = 0.001) and p105 and p130 (P = 0.002).
CONCLUSIONS: All tested factors related to cell cycle were increased, but only MI and cyclin A was an independent predictor of CIN3 and high-risk HPV carriage, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16835319     DOI: 10.1158/1055-9965.EPI-06-0086

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  4 in total

1.  Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma.

Authors:  Azza E El Bassiouny; Mona M Nosseir; Mona K Zoheiry; Noha A Ameen; Ahmed M Abdel-Hadi; Ibrahim M Ibrahim; Suher Zada; Abdel-Hakeem Saad El-Deen; Nora E El-Bassiouni
Journal:  World J Hepatol       Date:  2010-01-27

2.  Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.

Authors:  Stina Syrjänen; Paulo Naud; Luis Sarian; Sophie Derchain; Cecilia Roteli-Martins; Adhemar Longatto-Filho; Silvio Tatti; Margherita Branca; Mojca Erzen; L S Hammes; S Costa; Kari Syrjänen
Journal:  Virchows Arch       Date:  2009-11-12       Impact factor: 4.064

3.  Cyclin A1 shows age-related expression in benign tonsils, HPV16-dependent overexpression in HNSCC and predicts lower recurrence rate in HNSCC independently of HPV16.

Authors:  Daniel Weiss; Mario Koopmann; Türker Basel; Claudia Rudack
Journal:  BMC Cancer       Date:  2012-06-19       Impact factor: 4.430

4.  pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda.

Authors:  Sam Kalungi; Solrun J Steine; Henry Wabinga; Leif Bostad; Anders Molven
Journal:  BMC Clin Pathol       Date:  2009-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.